Rep. Price faced two hearings to vet his nomination, the first in the Senate health committee and the second in the Senate finance committee. At both hearings, Democrats grilled Rep. Price on his potential conflicts of interest in the stock market, as well as his views on drug prices, ACA replacement plans and Medicare and Medicaid. Republicans upheld Rep. Price’s qualifications and called the attacks on his ethics merely partisan politics.
Despite concerns from Democrats, The New York Times Washington correspondent Robert Pear wrote last week that Rep. Price is likely to be confirmed because he has strong support from Republicans who hold a majority in the Senate.
The session will be live-streamed at 10:00 a.m. ET here.
More articles on leadership and management:
Long Beach hospitals lay off 130 employees amid financial challenges
Cleveland Clinic, CEO of Mayo Clinic issue statements on Trump’s travel ban
Pre-existing condition bill to be introduced in House
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.